Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 109401-109450 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05685810
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
N/A
Active, not recruiting
3,029 participants
Started: May 1, 2018 · Completed: Jan 31, 2030
7 conditions
23 sponsors
1 location
NCT03522831
CF Bronchodilation
NA
Active, not recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03587922
FANTOM Post Market Clinical Trial
NA
Recruiting
1,500 participants
Started: May 1, 2018 · Completed: May 1, 2025
1 condition
1 sponsor
10 locations
NCT03541512
Remote Mindfulness Education PLV
NA
Enrolling by invitation
46 participants
Started: May 1, 2018 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03708952
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
N/A
Active, not recruiting
25,000 participants
Started: May 1, 2018 · Completed: May 1, 2028
2 conditions
3 sponsors
2 locations
NCT03368313
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
NA
Recruiting
120 participants
Started: May 1, 2018 · Completed: Nov 30, 2025
2 conditions
1 sponsor
18 locations
NCT03278119
Sleep Aging and Risk for Alzheimer's 2.0
N/A
Active, not recruiting
158 participants
Started: May 1, 2018 · Completed: Dec 25, 2025
2 conditions
2 sponsors
1 location
NCT03539575
CB1R in Synthetic Psychoactive Cannabinoids
NA
Active, not recruiting
15 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03745521
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
N/A
Active, not recruiting
226 participants
Started: May 1, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03346694
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
NA
Recruiting
660 participants
Started: May 1, 2018 · Completed: May 1, 2035
1 condition
1 sponsor
1 location
NCT03860558
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NA
Recruiting
40 participants
Started: May 1, 2018 · Completed: Jul 1, 2025
3 conditions
1 sponsor
1 location
NCT03422393
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
PHASE1
Active, not recruiting
24 participants
Started: May 1, 2018 · Completed: Aug 31, 2028
2 conditions
2 sponsors
1 location
NCT05764434
ALS Spinal Cord Gray and White Matter Study
N/A
Recruiting
80 participants
Started: May 1, 2018 · Completed: Oct 1, 2025
1 condition
1 sponsor
1 location
NCT02645266
Mean Visual Acuity Changes Following Five Injections of Aflibercept
NA
Active, not recruiting
48 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03860857
Biomarker Exploration in Aging, Cognition and Neurodegeneration
PHASE3
Recruiting
300 participants
Started: May 1, 2018 · Completed: Dec 22, 2027
3 conditions
2 sponsors
1 location
NCT03337932
Duration of Doxycycline Treatment in MEM Patients
NA
Recruiting
200 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04263298
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
PHASE3
Recruiting
210 participants
Started: May 1, 2018 · Completed: May 1, 2030
1 condition
1 sponsor
13 locations
NCT05461820
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
PHASE4
Recruiting
240 participants
Started: May 1, 2018 · Completed: Jul 31, 2030
4 conditions
1 sponsor
1 location
NCT03711617
Uremic Toxins and Outcomes in Chronic Kidney Disease
N/A
Recruiting
500 participants
Started: May 1, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03834844
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
NA
Active, not recruiting
50 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03400085
Pilot Study of an mHealth Intervention for Living Donor Follow-up
NA
Active, not recruiting
400 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
3 conditions
4 sponsors
2 locations
NCT04619524
Biomarkers of Endometrial Receptivity
NA
Recruiting
476 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
4 conditions
3 sponsors
3 locations
NCT03820310
Clinical Trial of Autologous Tcm Immunotherapy in ICC
PHASE2
Recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05679336
Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
NA
Recruiting
40 participants
Started: May 1, 2018 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT03507257
Longitudinal Early-onset Alzheimer's Disease Study Protocol
N/A
Recruiting
850 participants
Started: Apr 30, 2018 · Completed: May 31, 2026
3 conditions
4 sponsors
23 locations
NCT03523312
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
PHASE2
Active, not recruiting
47 participants
Started: Apr 30, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
8 locations
NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
PHASE3
Active, not recruiting
173 participants
Started: Apr 30, 2018 · Completed: Jun 30, 2026
4 conditions
2 sponsors
43 locations
NCT03207945
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
PHASE3
Recruiting
140 participants
Started: Apr 30, 2018 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT04207931
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
PHASE4
Recruiting
250 participants
Started: Apr 30, 2018 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT03796078
Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea
NA
Recruiting
80 participants
Started: Apr 30, 2018 · Completed: Dec 1, 2025
4 conditions
1 sponsor
1 location
NCT03282305
Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese
N/A
Not yet recruiting
5,000 participants
Started: Apr 30, 2018 · Completed: Dec 31, 2029
2 conditions
3 sponsors
0 locations
NCT03419481
Pembrolizumab in Hepatocellular Carcinoma
PHASE2
Active, not recruiting
30 participants
Started: Apr 30, 2018 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
PHASE2
Active, not recruiting
46 participants
Started: Apr 30, 2018 · Completed: Mar 31, 2026
5 conditions
5 sponsors
4 locations
NCT04273880
Differences by Sex and Genotype in the Effects of Stress on Executive Functions
PHASE1
Recruiting
146 participants
Started: Apr 28, 2018 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT03449108
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
PHASE2
Active, not recruiting
30 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2027
16 conditions
3 sponsors
1 location
NCT03412435
Asan Medical Center Myocardial Infarction Registry
N/A
Recruiting
5,000 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2030
2 conditions
2 sponsors
1 location
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
PHASE2
Active, not recruiting
196 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2026
4 conditions
2 sponsors
29 locations
NCT03523377
Overnight Fasting After Completion of Therapy: The OnFACT Study
NA
Active, not recruiting
28 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT04288323
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) Vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients with Cirrhosis
PHASE4
Recruiting
150 participants
Started: Apr 27, 2018 · Completed: Dec 30, 2025
3 conditions
3 sponsors
1 location
NCT03389477
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
26 participants
Started: Apr 27, 2018 · Completed: Apr 6, 2027
1 condition
2 sponsors
1 location
NCT03535831
PSMA PET Registry (18F-DCFPyL)
NA
Active, not recruiting
200 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03258567
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
PHASE2
Recruiting
40 participants
Started: Apr 26, 2018 · Completed: Jun 1, 2031
4 conditions
1 sponsor
1 location
NCT03419234
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
PHASE2
Active, not recruiting
223 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
5 conditions
2 sponsors
672 locations
NCT06968923
Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device
NA
Recruiting
90 participants
Started: Apr 26, 2018 · Completed: Apr 30, 2026
4 conditions
1 sponsor
1 location
NCT06041906
International Registry of Congenital Portosystemic Shunt (IRCPSS)
N/A
Enrolling by invitation
500 participants
Started: Apr 26, 2018 · Completed: Dec 31, 2028
2 conditions
4 sponsors
26 locations
NCT03282409
Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit
N/A
Active, not recruiting
425 participants
Started: Apr 26, 2018 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT03530826
A Crowd Sourcing Platform for Patients With Cancer
N/A
Recruiting
5,000 participants
Started: Apr 26, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03524430
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
NA
Recruiting
801 participants
Started: Apr 26, 2018 · Completed: Mar 31, 2031
1 condition
1 sponsor
7 locations
NCT03519997
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
PHASE2
Active, not recruiting
35 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT03548571
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PHASE2/PHASE3
Recruiting
60 participants
Started: Apr 26, 2018 · Completed: May 1, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
2186
2187
2188
2189
2190
2191
2192
More pages
2369
Next